Lhasa Limited shared knowledge shared progress

Lhasa Limited Newsletter February 2020

Date: 19 March 2020

Keep up with all of our latest news...
 
Company Logo
 

Lhasa Limited Newsletter

February 2020

News  |  Recent Releases  |  Upcoming Events  | Webinars Publications   

News

Save the date!

2020 EU Symposium

Location: Copenhagen, Denmark

Save the date for our European Symposium following the EuroTox conference in September 2020.

Thursday 10th September 2020

2020 US Symposium

Location: Austin, Texas

Save the date for our US Symposium following the ACT conference in November 2020.

Thursday 19th November 2020

ICH M7 India Roadshows

There's still time to register!

We're delighted to be once again holding our free, 1-day ICH M7 roadshow events in India. We will be holding an event in Mumbai in February and an event in Hyderabad in March this year

These events will cover an introduction to ICH M7 and provide an overview of how Derek Nexus, Sarah Nexus and Vitic, can facilitate with meeting the ICH M7 guideline. Register or view the agenda via the links opposite. 

Mumbai
Hyderabad

Effiris Web Pages Now Available

Effiris is a qualitative model suite for predicting the secondary pharmacology effects of your compounds. Read more about Effiris on our recently published web pages. 

Effiris Web Page

Lhasa Limited Releases New Data into its Carcinogenicity Database

Released in 2016 and founded on the recently retired Carcinogenic Potency Database (CPDB), the Lhasa Carcinogenicity Database (LCDB) is a vital source of long-term carcinogenicity study data. For more information, select the relevant link below. 

Press Release
LCDB Webpage

Recent Releases

Vitic Aromatic Amines 

Data Release 

October 29th 2019 

Read more

Upcoming Events

March

15th - 19th March 2020 | Society of Toxicology (SOT) 59th Annual Meeting and ToxExpo | Anaheim, USA

We're delighted to be attending the 2020 Society of Toxicology 59th Annual Meeting and ToxExpo. 

A team from Lhasa Limited will be attending and will be exhibiting at booth number 828. We will also be holding two exhibitor-hosted sessions. Find out more via the link opposite. 

SOT

April

1st - 3rd April 2020 | 29th Meeting of the ERGECD | Lyon, France

Lhasa Limited Senior Scientist, Martyn Chilton, will be attending and presenting.

ERGECD

20th - 22nd April 2020 | British Toxicology Society Annual Congress | Cardiff, Wales

Lhasa Limited Senior Scientist, David Ponting, will be attending and presenting on phototoxicity alert improvement. 

BTS

5th - 6th May 2020 | NYSCC Suppliers' Day | New York, USA

Lhasa Limited Sales Executive, Alex Vrijheid, will be attending and exhibiting at booth number 880.

NYSCC

6th - 7th May 2020 | GTA Annual Meeting | Delaware, USA

Lhasa Limited US Account Managers, Charles Modlin and Mersedeh Saniepay will be attending. 

GTA

Webinars

Using Nexus to aid expert review for ICH M7

Date: 24th March 2020, 15.00 (UK time)

Accessing Carcinogenicity Potency Data

Date: 1st April 2020, 15.00 (UK time)

Register
Register

The Application of Adverse Outcome Pathways (AOPs) for Risk Assessment

Date: 12th May 2020,15.00 (UK time)

Building Secondary Pharmacology Models: A Novel Approach to Proprietary Data Transfer

Date: 18th May 2020, 15.00 (UK time)

Register
Register

Publications

AIChE Annual Meeting

'Achieving Innovation Through Collaborative Progress.'

Presented by Lhasa Limited Senior Account Manager, Dave Yeo

ACEM/JEMS

 There are several presentations associated with this event. 

View Presentation
View Publications

JPAG - Regulatory Hot Topics IV

'The use of in-silico tools to assist in the practical management of impurities under ICH M7.'

Presented by Lhasa Limited Senior Account Manager, Dave Yeo

 

In Silico Toxicology Network Meeting

'Using an Adverse Outcome Pathway framework to ground approaches in predictive toxicology.'

Presented by Lhasa Limited Senior Scientist, Alun Myden.

View Presentation
View Talk

Webinar

Zeneth 8: A faster, more intuitive, degradation predictive system.

Presented by Lhasa Limited Head of Chemistry, Martin Ott and Senior Scientist, Ash Ali

View Recording

Webinar

Risk Assessment and Regulatory Decision Making for Alkyl Nitrosamines.

Presented by Senior Principal Scientist, Andrew Teasdale from AstraZeneca, and Associate Professor of Biomedical Sciences, George Johnson, from Swansea University.

View Recording

Writing a publication that includes Lhasa Limited or its products?

If you are writing a poster, presentation, paper or any other publication for external consumption, please check our citations page.

This page will provide you with useful information including logos, recommended citations and advice to ensure you stay within your license agreement.

Let's be social

Stay up to date with Lhasa's latest info, events, and discussions by connecting with us on social media. See our LinkedIn and Twitter pages via the links opposite. 

Website  | Member Area  | Events  | Publications Library 

 LinkedIn Twitter 
 
 
  • Summary:
  • Categories:

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.